Baird Medical's Sterile Biopsy Needle Gains Approval from Jiangsu Medical Products Administration in China.

06 September 2023 | Wednesday | News

Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China, announced that its subsidiary, Nanjing Changcheng Medical Equipment Co., Ltd., has received approval of its Single-Use Sterile Biopsy Needle ("SSBN") from Jiangsu Medical Products Administration, the drug regulatory body for Jiangsu Province in China. Approved on August 30, 2023 with registration number 20232141234, the product is used for biopsies of tumors in superficial tissues located close to the skin surface, such as in breasts, thyroid, and lymph nodes.
Image Source | Public Domain

Image Source | Public Domain

Baird Medical's MWA products have been available in China for many years, and the Company is known as a market leader in MWA technology for thyroid and breast nodules. This technology offers minimally invasive treatment methods, providing both precision and reduced complications while improving the overall patient experience.

Ms. Haimei Wu, Founder and CEO of Baird Medical, said, "Securing approval for our SSBN technology both strengthens our company's pipeline and provides medical personnel with biopsy products that complement MWA procedures."

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close